In conclusion, we show that low fD levels (< 0.5 μg mL−1) result in a more indolent complement activation response, revealing a type of immunodeficiency that may become clinically overt only in the absence of sufficient antibody‐mediated CP activation and during bacterial infections that require a rapidly accelerating complement activation response. The gene discussed is CP; the disease is immune system disorder.